Attention deficit-hyperactivity disorder in children and adolescents

New England Journal of Medicine

Volumn 370, Issue 9, 2014, Pages 838-846

  Feldman, Heidi M ^a   Reiff, Michael I ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOSTIMULANT AGENT; CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD CARE; CLINICAL FEATURE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG USE; GENETIC PREDISPOSITION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; RISK FACTOR; THERAPY EFFECT; ADOLESCENT; CHILD; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; REVIEW;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; HUMANS; MALE; METHYLPHENIDATE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 84896697405     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1307215     Document Type: Article

References (52)

1. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, DC: American Psychiatric Association, 2000.
2. Diagnostic and statistical manual of mental disorders, fifth edition (DSM-5). Washington, DC: American Psychiatric Association, 2013.
3. Biederman J, Petty CR, Woodworth KY, Lomedico A, Hyder LL, Faraone SV. Adult outcome of attention-deficit/hyperactivity disorder: a controlled 16-year follow-up study. J Clin Psychiatry 2012;73:941-50.
4. Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. Ambul Pediatr 2007;7:Suppl:82-90. (Pubitemid 46140760)
5. Hoza B. Peer functioning in children with ADHD. Ambul Pediatr 2007;7:Suppl:101-6. (Pubitemid 46140753)
6. Molina BSG, Hinshaw SP, Swanson JM, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009;48:484-500.
7. Garcia CR, Bau CHD, Silva KL, et al. The burdened life of adults with ADHD: impairment beyond comorbidity. Eur Psychiatry 2012;27:309-13.
8. Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 2007;32:711-27. (Pubitemid 47356048)
9. Pastor PN, Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital Health Stat 10 2008;237:1-14.
10. Boyle CA, Boulet S, Schieve LA, et al. Trends in the prevalence of developmental disabilities in US children, 1997-2008. Pediatrics 2011;127:1034-42.
11. Fulton BD, Scheffler RM, Hinshaw SP, et al. National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. Psychiatr Serv 2009;60:1075-83.
12. Schwarz A. The selling of attention deficit disorder. New York Times. December 14, 2013.
13. Carlson CL, Mann M. Attention-deficit/hyperactivity disorder, predominantly inattentive subtype. Child Adolesc Psychiatr Clin N Am 2000;9:499-510. (Pubitemid 30620540)
14. Neuman RJ, Sitdhiraksa N, Reich W, et al. Estimation of prevalence of DSM-IV and latent class-defined ADHD subtypes in a population-based sample of child and adolescent twins. Twin Res Hum Genet 2005;8:392-401. [Erratum, Twin Res Hum Genet 2005;8:542.] (Pubitemid 41152913)
15. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-8. (Pubitemid 46972911)
16. Fergusson DM, Lynskey MT, Horwood LJ. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiatry 1997;38:633-44. (Pubitemid 27437729)
17. Merrell C, Tymms PB. Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress. Br J Educ Psychol 2001;71:43-56. (Pubitemid 33652104)
18. The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organization, 1993.
19. Lee SI, Schachar RJ, Chen SX, et al. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. J Child Psychol Psychiatry 2008;49:70-8.
20. Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 2010;33:159-80.
21. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006;114:1904-9. (Pubitemid 44873693)
22. Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2011;13:333-44.
23. Shaw P, Eckstrand K, Sharp W, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A 2007;104:19649-54.
24. Dickstein SG, Bannon K, Castellanos FX, Milham MP. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry 2006;47:1051-62. (Pubitemid 44642434)
25. Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the prefrontal-striatal model. Trends Cogn Sci 2012;16:17-26.
26. Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-22.
27. International classification of functioning, disability, and health (ICF). Geneva: World Health Organization, 2001.
28. International classification of functioning, disability and health - version for children and youth: ICF-CY. Geneva: World Health Organization, 2007.
29. Ustün TB. Using the international classification of functioning, disease and health in attention-deficit/hyperactivity disorder: separating the disease from its epiphenomena. Ambul Pediatr 2007;7:Suppl:132-9. (Pubitemid 46140758)
30. The medical home. Pediatrics 2002;110:184-6.
31. What is a family-centered medical home? Elk Grove Village, IL: American Academy of Pediatrics, 2005 (http://www.medicalhomeinfo.org).
32. Biederman J, Quinn D, Weiss M, et al. Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder. Paediatr Drugs 2003;5:833-41. (Pubitemid 38030609)
33. Faraone SV, Short EJ, Biederman J, Findling RL, Roe C, Manos MJ. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol 2002;5:121-9. (Pubitemid 34662974)
34. Schachar R, Jadad AR, Gauld M, et al. Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Can J Psychiatry 2002;47:337-48. (Pubitemid 34728754)
35. Efron D, Jarman F, Barker M. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997;100:E6.
36. Subcommittee on Attention-Deficit/Hyperactivity Disorder Steering Committee on Quality Improvement Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1-16.
37. Pelham WE Jr, Fabiano GA. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol 2008;37:184-214.
38. Antshel KM, Barkley R. Psychosocial interventions in attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2008;17:421-37. (Pubitemid 351258354)
39. Parent training programs: insight for practitioners. Atlanta: Centers for Disease Control and Prevention, 2009.
40. DuPaul G, Eckert T, Vilardo B. The effects of school-based interventions for attention deficit/hyperactivity disorder: a meta-analysis 1996-2010. School Psychol Rev 2012;41:387-412.
41. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1073-86.
42. Idem. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999;56:1088-96.
43. Greenhill L, Kollins S, Abikoff H, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45:1284-93. [Erratum, J Am Acad Child Adolesc Psychiatry 2007;46:141.] (Pubitemid 44665445)
44. Reid R, Hakendorf P, Prosser B. Use of psychostimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 2002;41:906-13. (Pubitemid 38338069)
45. Perrin JM, Friedman RA, Knilans TK. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics 2008;122:451-3.
46. Cooper WO, Habel LA, Sox CM, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011;365:1896-904.
47. Poulton A. Growth on stimulant medication; clarifying the confusion: a review. Arch Dis Child 2005;90:801-6. (Pubitemid 41081356)
48. Diamond A, Barnett WS, Thomas J, Munro S. Preschool program improves cognitive control. Science 2007;318:1387-8. (Pubitemid 350208940)
49. Clark C, Sörqvist P. A 3 year update on the influence of noise on performance and behavior. Noise Health 2012;14:292-6.
50. Weber W, Newmark S. Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism. Pediatr Clin North Am 2007;54:983-1006. (Pubitemid 350179896)
51. Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications. Neurology 2013;80:1251-60.
52. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-921.